Chemical Permeation Enhancers for Local Anesthetic Nerve Block
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current local anesthetics require higher concentrations to be effective due to their difficulty in penetrating biological barriers, leading to systemic toxicity and limited duration of nerve block.
Innovation Solution
Combining site I sodium channel blockers with chemical penetration enhancers, such as surfactants, to improve the potency and efficacy of local anesthetics, thereby reducing systemic toxicity and prolonging nerve block duration without increasing local toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If higher concentrations of local anesthetics are used to improve penetration through biological barriers, then the efficacy of nerve block is improved, but systemic toxicity increases
Solution Approach 1:
Chemical permeation enhancers act as intermediary substances that facilitate the transport of local anesthetics through biological barriers (epineurium, perineurium, endoneurium). These enhancers modify the barrier properties temporarily, allowing adequate drug delivery at lower concentrations, thus maintaining nerve block efficacy while reducing systemic toxicity.
Solution Approach 2:
The invention changes the physical-chemical parameters of the biological barrier by introducing chemical permeation enhancers that alter membrane permeability. This allows the local anesthetic to achieve effective concentrations at the nerve site without requiring high systemic concentrations, thereby resolving the contradiction between efficacy and toxicity.
2Duration of action of moving object
If higher concentrations of local anesthetics are used to achieve effective nerve block, then the duration of action is improved, but local tissue toxicity increases
Solution Approach 1:
Chemical permeation enhancers serve as mediators that enable sustained drug delivery to the nerve by modifying barrier permeability. This allows the local anesthetic to maintain effective concentrations over extended periods without requiring high initial concentrations that would cause local tissue damage.
3Device complexity
If conventional local anesthetics are used without permeation enhancers, then the formulation is simple, but the potency and efficacy are limited
Solution Approach 1:
The invention creates a composite formulation combining local anesthetics with chemical permeation enhancers. This composite approach leverages the complementary properties of both components: the anesthetic provides the therapeutic effect while the enhancer facilitates delivery, resulting in superior potency and efficacy compared to conventional single-component formulations.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination significantly prolongs nerve block duration with minimal local tissue toxicity, enhancing the clinical applicability of site I sodium channel blockers like tetrodotoxin for prolonged-duration local anesthesia.
Implementation Method 1
Surfactants, a heterogeneous group of amphiphilic organic molecules with hydrophilic heads and hydrophobic tails, are a well-known class of CPEs
Implementation Method 2
Chemical permeation enhancers (CPEs) have been used to increase the permeability of the lipid-protein barriers of the skin, and thereby increase drug flux
Implementation Method 3
A method currently used in medical practice is the co-administration of vasoconstrictors such as epinephrine (adrenaline), phenylephrine, or norepinephrine, which increase the residence time of the drug at the site of administration, due to the induction of vasoconstriction with subsequent reduction of systemic uptake
Implementation Method 4
Combinations of site I sodium channel blocker local anesthetics with chemical penetration enhancers have been developed to improve the potency and efficacy of local anesthetics
Data Source
AI summary
Chemical permeation enhancers (CPEs) improve access of local anesthetics to the nerve, thereby improving their performance. Surfactants, representing three CPE sub-groups: anionic, cationic, and nonionic surfactants, were co-injected with tetrodotoxin (TTX) or bupivacaine at the sciatic nerve of Sprague-Dawley rats. All enhancers produced marked concentration-dependent improvements in the frequency and duration of block with TTX but not bupivacaine. An in vitro toxicity assay showed a wide range of CPE myotoxicity, but in vivo histological assessment showed no signs of muscle or nerve damage at concentrations of CPEs that produced a half-maximal increase in the duration of block of TTX. There was no systematic relationship between the enhancers' charge or hydrophobicity and their enhancement of block duration or potency. Thus, CPEs can provide marked prolongation of nerve blockade from TTX, without apparent local tissue toxicity, and therefore enhance the clinical applicability of TTX for prolonged-duration local anesthesia.